Overview
Kazumasa Wakamatsu practices practicing medicine in Toyoake, Japan.
Wakamatsu is highly rated in 7 conditions, according to our data. Their clinical expertise encompasses Oculocutaneous Albinism Type 1, Oculocutaneous Albinism Type 2, Oculocutaneous Albinism, and Hermansky-Pudlak Syndrome.
They are actively involved in clinical research, co-authoring 184 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kazumasa Wakamatsu
Is Kazumasa Wakamatsu a top-rated expert for Oculocutaneous Albinism Type 1?
MediFind is an objective health platform that identifies experts based on real-world data. Kazumasa Wakamatsu is classified as an Distinguished expert for Oculocutaneous Albinism Type 1, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kazumasa Wakamatsu participate in research or clinical trials?
Yes. Kazumasa Wakamatsu has published 184 articles and abstracts on conditions like Oculocutaneous Albinism Type 1. You can view a list of Kazumasa Wakamatsu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AlbinismWakamatsu isDistinguished. Learn about Albinism.
- Hermansky-Pudlak SyndromeWakamatsu isDistinguished. Learn about Hermansky-Pudlak Syndrome.
- Hypomelanotic DisorderWakamatsu isDistinguished. Learn about Hypomelanotic Disorder.
- Oculocutaneous AlbinismWakamatsu isDistinguished. Learn about Oculocutaneous Albinism.
- Oculocutaneous Albinism Type 1Wakamatsu isDistinguished. Learn about Oculocutaneous Albinism Type 1.
- Oculocutaneous Albinism Type 2Wakamatsu isDistinguished. Learn about Oculocutaneous Albinism Type 2.
- Advanced
- MelanomaWakamatsu isAdvanced. Learn about Melanoma.
- Experienced
- MelasmaWakamatsu isExperienced. Learn about Melasma.
- Movement DisordersWakamatsu isExperienced. Learn about Movement Disorders.
- Neuroendocrine TumorWakamatsu isExperienced. Learn about Neuroendocrine Tumor.
- Neurotoxicity SyndromesWakamatsu isExperienced. Learn about Neurotoxicity Syndromes.
- OchronosisWakamatsu isExperienced. Learn about Ochronosis.
- Parkinson's DiseaseWakamatsu isExperienced. Learn about Parkinson's Disease.
- Platelet Storage Pool DeficiencyWakamatsu isExperienced. Learn about Platelet Storage Pool Deficiency.
- SunburnWakamatsu isExperienced. Learn about Sunburn.
- VitiligoWakamatsu isExperienced. Learn about Vitiligo.
- Waardenburg SyndromeWakamatsu isExperienced. Learn about Waardenburg Syndrome.
- Waardenburg Syndrome Type 1Wakamatsu isExperienced. Learn about Waardenburg Syndrome Type 1.
- Xeroderma PigmentosumWakamatsu isExperienced. Learn about Xeroderma Pigmentosum.